These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33836954)

  • 1. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
    Cabanie C; Biau J; Durando X; Mansard S; Molnar I; Chassin V; Verrelle P; Khalil T; Lapeyre M; Dupic G
    Cancer Radiother; 2021 Jul; 25(5):432-440. PubMed ID: 33836954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
    Enright TL; Witt JS; Burr AR; Yadav P; Leal T; Baschnagel AM
    Clin Lung Cancer; 2021 Mar; 22(2):110-119. PubMed ID: 33281062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
    Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
    Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases.
    Dupic G; Brun L; Molnar I; Leyrat B; Chassin V; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
    Radiother Oncol; 2021 Jan; 154():260-268. PubMed ID: 33245944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis.
    Zhang J; Yu J; Yang D; Jiang L; Dong X; Liu Z; Yu R; Yu H; Shi A
    Front Immunol; 2024; 15():1399613. PubMed ID: 39257576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery with immunotherapy is associated with improved overall survival in patients with metastatic melanoma or non-small cell lung cancer: a National Cancer Database analysis.
    Jiang JM; Kabarriti R; Brodin NP; Ohri N; Guha C; Kalnicki S; Garg M
    Clin Transl Oncol; 2022 Jan; 24(1):104-111. PubMed ID: 34236616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [First-line immunotherapy in non-small cell lung cancer diagnosed with brain metastases].
    Nigen B; Bodergat T; Vaugier L; Pons-Tostivint E
    Rev Mal Respir; 2024 Oct; 41(8):571-582. PubMed ID: 38926022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
    Cohen-Inbar O; Shih HH; Xu Z; Schlesinger D; Sheehan JP
    J Neurosurg; 2017 Nov; 127(5):1007-1014. PubMed ID: 28059663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of patients with brain metastases from a melanoma].
    Modesto A; Chira C; Sol JC; Lubrano V; Boulinguez S; Pagès C; Sibaud V; Gomez-Roca C; Moyal É; Meyer N
    Cancer Radiother; 2019 Apr; 23(2):147-150. PubMed ID: 30904418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
    Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
    Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
    Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
    Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
    Kaidar-Person O; Zagar TM; Deal A; Moschos SJ; Ewend MG; Sasaki-Adams D; Lee CB; Collichio FA; Fried D; Marks LB; Chera BS
    Anticancer Drugs; 2017 Jul; 28(6):669-675. PubMed ID: 28368903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiotherapy for large solitary brain metastases.
    Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
    Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
    Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
    Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.